Bathi saben saham sajrone rolas wulan pungkasan: Curis Inc. (CRIS)
Patent protection for inhibitors and influence within the US oncology sphere create significant barriers for competitors of Curis, Inc. (CRIS). The 12-month EPS change illustrates profit dynamics, where -6.37 shows the current value of the metric. High binary risks resulting from a narrow development pipeline are offset by stable royalties from partners, providing the company with a consistent cash flow.
Ringkesan rincian data analitis Curis, Inc. (CRIS)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Curis, Inc.|CRIS - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Curis|CRIS - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Curis|CRIS - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Curis|Indikator likuiditas cepet curis.com
- indikator pendapatan resik lan kelipatan nilai:
CRIS - Bathi pungkasan|Proyeksi bathi mangsa ngarep Curis, Inc.|CRIS - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Curis Inc.|CRIS - Rasio P/E diaturake wutah|Pangali EV/EBITDA Curis, Inc.|CRIS - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Curis|CRIS - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan curis.com|CRIS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Curis, Inc.
- data pendapatan lan penerimaan dodolan:
Analisis umum perusahaan:Curis, Inc. (CRIS)
A conservative approach to analyzing Curis, Inc. (CRIS) requires a priority assessment of the actual return on equity. This metric is calculated by dividing the total annual net income by the total number of shares outstanding. By analyzing the earnings per share over the last four quarters, an investor determines the effectiveness of the monetization of developments. Under US intellectual property protections, this metric reflects the financial stability of oncological research. A stable trend confirms the safety of investments in the high-tech biopharmaceutical sector.
Pesaing Curis, Inc.
ONC - Bathi saben saham sajrone rolas wulan pungkasan|HALO - Bathi resik saben saham (EPS TTM)|RevMed (RVMD) - Bathi saben saham sajrone rolas wulan pungkasan|Ascentage - Bathi saben saham sajroning taun lumaku|CGON (CG Oncology Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan UroGen Pharma URGN|Bathi resik saben saham (EPS TTM) BCAX|PSNL: Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Erasca Corp ERAS|Delcath Corp (DCTH) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|YMAB - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku AURA (Aura Biosciences, Inc.)|CADL: Bathi resik saben saham (EPS TTM)|Accuray Inc (ARAY) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan SELLAS Life Sciences Group|Bathi resik saben saham (EPS TTM) Actuate Therapeutics, Inc.|Bathi saben saham sajrone rolas wulan pungkasan citiusonc.com (CTOR)|Bathi resik saben saham (EPS TTM) TuHURA (HURA)|Bathi resik saben saham (EPS TTM) TARA (protaratx.com)|Bathi saben saham sajroning taun lumaku FATE|WHWK - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku TCRX (tscan.com)|Champions Oncology (CSBR) - Bathi saben saham sajrone rolas wulan pungkasan|XBiotech Inc - Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan cel-sci.com|OS Therapies (OSTX) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan RADX (Radiopharm Theranostics Limited)|Bathi saben saham sajrone patang kuartal pungkasan ARTV|Adlai Nortye Ltd. - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku VERU|tempesttx.com - Bathi resik saben saham (EPS TTM)|XLO - Bathi resik saben saham (EPS TTM)|Enochian BioSciences (RENB) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Mural Oncology plc (MURA)|Bathi saben saham sajrone rolas wulan pungkasan Kairos Pharma Ltd|Bathi resik saben saham (EPS TTM) OnKure Therapeutics|Bathi resik saben saham sajrone 12 wulan pungkasan GDTC (w2.cytomed.sg)|Bathi resik saben saham (EPS TTM) Apollomics Inc. (APLM)|Bathi resik saben saham (EPS TTM) THAR (Tharimmune Corp)|Bathi resik saben saham sajrone patang kuartal pungkasan Advanced Biomed Inc (ADVB)|Genprex Inc - Bathi resik saben saham (EPS TTM)|CLDI - Bathi resik saben saham (EPS TTM)|Sunshine Biopharma Inc. (SBFM) - Bathi saben saham sajrone rolas wulan pungkasan|XBIO - Bathi resik saben saham sajrone patang kuartal pungkasan|SLRX (Salarius Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Kitov Pharma|Bathi resik saben saham sajrone 12 wulan pungkasan AONC (American Oncology Network)|BGNE - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi resik saben saham (EPS TTM) CKPT (Checkpoint Therapeutics Inc.)|Elevation Oncology, Inc. - Bathi saben saham sajrone rolas wulan pungkasan|ICAD - Bathi saben saham sajrone rolas wulan pungkasan|IKNA - Bathi resik saben saham (EPS TTM)|Notable Labs (NTBL) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone 12 wulan pungkasan VIRX|MOR (MorphoSys Corporation) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan NAYA Biosciences Inc NAYA|Bathi saben saham sajrone rolas wulan pungkasan Ascentage Pharma (AAPGV)
